Treatment of age-related macular degeneration: focus on ranibizumab

Ranibizumab, a humanized antigen-binding fragment (Fab) that binds all isoforms of VEGF-A, significantly slows down loss of vision and causes significant visual improvement in many patients with choroidal neovascularization (CNV) due to exudative age-related macular degeneration (AMD). These benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Spitzer, Martin S, Ziemssen, Focke, Bartz-Schmidt, Karl U, Gelisken, Faik, Szurman, Peter
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698673/
https://www.ncbi.nlm.nih.gov/pubmed/19668384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2698673/
https://www.ncbi.nlm.nih.gov/pubmed/19668384

Ejemplares similares